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Periodontitis is a chronic inflammation of the periodontium caused by persistent bacterial
infection that leads to the breakdown of connective tissue and bone. Because the ability
to reconstruct the periodontium is limited after alveolar bone loss, early diagnosis and
intervention should be the primary goals of periodontal treatment. However, periodontitis
often progresses without noticeable symptoms, and many patients do not seek
professional dental care until the periodontal destruction progresses to the point of no
return. Furthermore, the current diagnosis of periodontitis depends on time-consuming
clinical measurements. Therefore, there is an unmet need for near-patient testing to
diagnose periodontitis. Saliva is an optimal biological fluid to serve as a near-patient
diagnostic tool for periodontitis. Recent developments in point-of-care (POC) testing
indicate that a diagnostic test for periodontitis using saliva is now technically feasible.
A number of promising salivary biomarkers associated with periodontitis have been
reported. A panel of optimal biomarkers must be carefully selected based on the
pathogenesis of periodontitis. The biggest hurdle for the POC diagnosis of periodontitis
using saliva may be the process of validation in a large, diverse patient population.
Therefore, we propose the organization of an International Consortium for Biomarkers of
Periodontitis, which will gather efforts to identify, select, and validate salivary biomarkers
for the diagnosis of periodontitis.
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Usefulness of Salivary Diagnostics for Periodontitis
Periodontitis is a chronic inflammation of the periodontium caused by persistent bacterial
infection that leads to the breakdown of connective tissue and bone (Ji et al., 2014). Due
to its chronic nature, periodontitis progresses without causing severe discomfort in the oral
cavity, and patients often seek professional care only after the periodontium is considerably
destroyed. Thus, there is a need to diagnose periodontitis in its initial stages using an easy,
safe, and easily accessible method. Periodontitis is currently diagnosed using radiography and
clinical measurements of probing pocket depth (PD), bleeding on probing (BOP), and clinical
attachment level (CAL) (Salvi et al., 2008). However, these traditional clinical measurements are
time-consuming and yield limited information because they are indicators of previous periodontal
disease rather than present disease activity.Moreover, they are inadequate for predicting susceptible
individuals who might be at risk of periodontitis in the future. The best predictor of gingival
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inflammation to date is BOP, but there are too many false
positives associated with this method (Lang et al., 1990).
There is an unmet need for near-patient testing to diagnose
periodontitis.
Saliva is an optimal biological fluid to serve as the diagnostic
tool for periodontitis. The collection of saliva is safe, non-
invasive, and simple, and saliva can be collected repeatedly with
minimum discomfort to the patient. A number of promising
biomarkers have been already identified in saliva that correlate
with the clinical parameters of periodontitis (Miller et al., 2010;
AlMoharib et al., 2014; Taylor, 2014). Saliva contains locally
produced proteins, genetic/genomic biomarkers such as DNA
and mRNA, and various metabolites that originate from the
host and the bacteria (Cuevas-Córdoba and Santiago-García,
2014). However, the diagnosis of periodontitis using saliva has
a limitation in detecting disease activity at each individual tooth
site; traditional clinical measurements are required in order to
accomplish this. In this respect, the diagnosis of periodontitis
using saliva must be realized as a point-of-care (POC) testing.
POC testing is defined as medical testing conducted outside
of a laboratory at or near the site of patient care, including
the patient’s bedside, the doctor’s office, and the patient’s
home (Song et al., 2014). If periodontitis is diagnosed by a
POC device using saliva, patients could easily diagnose their
periodontitis at home and visit dental clinics at a suitable
time. In dental clinics, current disease activity and responses to
treatment can be easily monitored at a chair-side. A POC device
for diagnosing periodontitis would also assist medical doctors
in assessing the periodontal status of their patients because
periodontitis is associated with many systemic diseases, such as
atherosclerosis, coronary heart disease, diabetes mellitus, and
rheumatoid arthritis (Scannapieco, 2005; Kobayashi and Yoshie,
2015). When medical doctors prescribe bisphosphonate or other
medicines associated with medication-related osteonecrosis of
the jaw (MRONJ), they can consider the periodontal status of
their patients in advance to prevent the development of MRONJ,
a common complication of medication combined with tooth
extraction (Katsarelis et al., 2015). Recent developments in POC
testing indicate that the diagnosis of periodontitis using saliva is
now technically feasible.
POC Technologies for Molecular
Diagnostics
Technologies for detecting biomarker signals in biofluids
have advanced significantly. In particular, the combination of
microfluidic and lab-on-a-chip technologies allows for real-time
monitoring of biomarkers in a small volume of a bodily fluid
at POC sites (Sackmann et al., 2014). Lab-on-a-chip approaches
integrate processing steps such as sampling, sample preparation,
detection, and data analysis into one small device (Su et al., 2015).
Microfluidics-based devices can analyze diverse clinical samples,
including blood, saliva, nasal aspirate, and urine (Su et al., 2015).
Diagnostic targets detected by POC technologies include
nucleic acids, proteins, metabolites and other small molecules
(Song et al., 2014; Su et al., 2015). For example, nucleic acid
can be amplified by on-chip PCR (non-isothermal) or on-chip
isothermal amplification techniques (Su et al., 2015). Many PCR-
based POC devices for the detection of pathogens such as
influenza, RSV, HIV, Methicillin-resistant Staphylococcus aureus,
Clostridium difficile, and malaria are already commercially
available (Su et al., 2015). POC DNA tests have also been
developed to detect genetic mutations associated with various
cancers (Yang et al., 2014). The microfluidic detection of protein
biomarkers generally relies on antibody-based immunoassays.
Aptamers, DNA, or RNA oligonucleotides designed to bind
to various biomolecules with high specificity and sensitivity
are an alternative to antibodies (Toh et al., 2015). The simple
lateral flow assay is rapid and specific but not sensitive or
quantitative. Diverse new technologies have been developed to
improve sensitivities and to allow for quantitative measurements
of multiplex protein biomarkers (Gaster et al., 2009; Warsinke,
2009; Rissin et al., 2010; de la Rica and Stevens, 2012). Glucose is
the best-known metabolite targeted by POC testing, with a long
history of use (Wilkins and Atanasov, 1996). Now a much wider
range of analytes can be quantified using POC technology (Sia
and Chin, 2011). For example, the i-STAT POC device, millions
of which are sold annually, electrochemically measures blood gas
(pH, PCO2, PO2, TCO2, HCO3, base excess, and sO2), electrolyte
(sodium, potassium, chloride, TCO2, anion gap, ionized calcium,
glucose, urea nitrogen, creatinine, and lactate), and hematology
(hematocrit and hemoglobin) parameters (Lauks, 1998). A
microfluidic device that measures nitric oxide has also been
developed (Halpin and Spence, 2010).
Various approaches have been developed to detect the target
molecules, but optical detection and electrochemical detection
are the ones most commonly adopted. Optical detectionmethods
implemented in POC devices include absorbance colorimetry,
chemiluminescence, fluorescence, surface-enhanced Raman
scattering spectroscopy, and surface plasmon resonance (Gubala
et al., 2012; Su et al., 2015). Electrochemical detection methods
include amperometric, potentiometric, and impedimetric
measurements (Su et al., 2015).
Salivary Biomarkers of Periodontitis
Ideal biomarkers of periodontitis must be able to (1) diagnose
the presence of periodontal disease, (2) reflect the severity of
the disease (3) monitor the response of the disease to treatment,
and (4) predict the prognosis/progress of the disease. A number
of biomarkers that satisfy at least one of the four requirements
have been identified in saliva (Tables 1–4). Salivary biomarkers
of periodontal disease can originate from both bacteria and
the host. As periodontitis progresses, gingival inflammation,
soft tissue destruction, and bone destruction occur sequentially
and release associated proteins or metabolites into the saliva.
Therefore, host-derived biomarkers are categorized according
to whether they reflect inflammation, soft tissue destruction, or
bone destruction. The biomarkers that satisfy three of the four
requirements in at least three separate studies are classified as
strong (S) biomarkers. When the number of studies that reported
no difference or contradictory results is equal or greater than
those with supporting results, the biomarkers are classified as
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TABLE 1 | Bacteria-derived salivary biomarkers.
Salivary biomarkers Supporting reports No difference or contradictory reports Strength
References Study size† References Study size
DNA Porphyromonas gingivalis von Troil-Lindén et al., 1995 (C); Sawamoto et al., 2005
(I)*; Ramseier et al., 2009 (C); Saygun et al., 2011 (C);
Nomura et al., 2012 (L); Pereira et al., 2012 (I)
512 S
Prevotella intermedia von Troil-Lindén et al., 1995 (C); Ramseier et al., 2009 (C);
Saygun et al., 2011 (C); Nomura et al., 2012 (L); Pereira
et al., 2012 (I)
463 S
Tannerella forsythia Sawamoto et al., 2005 (C)*; Ramseier et al., 2009 (C);
Saygun et al., 2011 (C); Pereira et al., 2012 (I)
387 Nomura et al., 2012 (L) 85 S
Treponema denticola Ramseier et al., 2009 (C); Pereira et al., 2012 (I) 188 P
Campylobacter rectus von Troil-Lindén et al., 1995 (C); Ramseier et al., 2009 (C);
Saygun et al., 2011 (C)
289 Pereira et al., 2012 (I) 89 P
Pseudomonas aeruginosa +
Acinetobacter spp.
Souto et al., 2014 (C) 224 P
Peptostreptococcus micros von Troil-Lindén et al., 1995 (C) 40 P
Fusobacterium nucleatum Saygun et al., 2011 (C) 150 Ramseier et al., 2009 (C) 99 Q
Aggregatibacter
actinomycetemcomitans
von Troil-Lindén et al., 1995 (C); Saygun et al., 2011 (C) 190 Sawamoto et al., 2005 (C);
Pereira et al., 2012 (I)
138 Q
Proteins Dipeptidyl peptidase Aemaimanan et al., 2009 (C)* 90 P
†Combined from multiple studies, C, cross-sectional study; L, longitudinal study; I, interventional study; *, correlation with clinical parameters; S, strong; P, potential; Q, questionable.
questionable (Q). The remaining biomarkers are classified as
potential (P).
Bacteria-derived Biomarkers
Bacteria-derived biomarkers include DNA and proteins. The
levels of well-known pathogenic bacteria, such as Aggregatibacter
actinomycetemcomitans, the three red complex species, and
several species of the orange complex in saliva were determined
by targeting a specific area of the 16S rRNA gene (Table 1).
Among them, only Porphyromonas gingivalis, Prevotella
intermedia, and Tannerella forsythia have been proved by
multiple studies as strong biomarkers of periodontitis. Recent
studies using high-throughput sequencing of the 16S rRNA gene
have identified new species/phylotypes that are associated with
periodontitis (Griffen et al., 2012; Göhler et al., 2014). Given
the complexity of dental biofilm, the potential of the newly
identified species/phylotypes to serve as salivary biomarkers of
periodontitis needs to be investigated. The activity of dipeptidyl
peptidase IV in saliva has been shown to be associated with
periodontitis and the presence of P. gingivalis (Aemaimanan
et al., 2009). Dipeptidyl peptidase IV is a serine protease that
cleaves X-Pro dipeptide from the N-terminus of polypeptide
chains, thus contributing to collagen degradation (Banbula et al.,
2000). DPP4 in saliva may originate from both the host and
bacteria, including P. gingivalis (Aemaimanan et al., 2009).
Host-derived Inflammatory Biomarkers
Periodontitis begins with inflammation of the gingival tissue
in response to dental biofilm. As inflammatory biomarkers
in saliva, diverse enzymes (arginase, dipeptidyl peptidase IV,
β-glucuronidase, and myeloperoxidase), anti-microbial proteins
(lactoferrin and calprotectin), inflammatory cytokines (IL-1β,
IL-6, IL-18, IFN-γ, and MIP-1α), and proteins that mediate
inflammation (chemerin, CRP, TLR4, soluble CD14, and
procalcitonin) have been studied (Table 2). Particularly, IL-1β,
MIP-1α, and arginase are strong biomarkers that correlate with
inflammatory parameters of periodontitis, such as the gingival
index or BOP (Miller et al., 2006; Gheren et al., 2008; Al-
Sabbagh et al., 2012; Rathnayake et al., 2013). In addition
to protein biomarkers, nitric oxide, 8-hydroxydeoxyguanosine,
platelet activating factor and fatty acid metabolites (neopterin,
docosapentaenoate, linoleate, and arachidonate) have been
identified as inflammation-associated biomarkers in saliva
(Table 2).
Host-derived Biomarkers Associated with Soft
Tissue Destruction
As periodontitis progresses, soft tissues are destroyed, releasing
several enzymes and proteins that are involved in tissue
destruction into the saliva. Among them, MMP-8, MMP-9,
HGF, lactate dehydrogenase, aspartate aminotransferase, and
TIMP-2 are strong or potential biomarkers of periodontitis
(Table 3). In addition, a recent metabolomic profiling of saliva
revealed increased amounts of metabolites originated from
macromolecular degradation, including dipeptides (proteins),
oligo/mono-saccharides (polysaccharides), lysolipids, fatty acids,
and monoacylglycerol (glycerophospholipid and triacylglycerol),
and uridine (DNA/RNA) in periodontitis (Table 3).
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TABLE 2 | Host-derived salivary biomarkers associated with inflammation.
Salivary biomarkers Supporting reports No difference or contradictory reports Strength
References Study size† References Study size
Proteins IL-1β Miller et al., 2006 (C)*; Ng et al., 2007 (C)*;
Christodoulides et al., 2007 (C); Scannapieco et al.,
2007 (L); Tobon-Arroyave et al., 2008 (C)*; Fine et al.,
2009 (L)*; Gursoy et al., 2009 (C); Mirrielees et al.,
2010 (C); Yoon et al., 2012 (C); Rathnayake et al.,
2013 (C)*; Ebersole et al., 2013 (C); Fine et al., 2014 (L)
1396 Teles et al., 2009 (C);
Ramseier et al., 2009 (C)
217 S
MIP-1α Fine et al., 2009 (L)*; Al-Sabbagh et al., 2012 (C)*; Fine
et al., 2014 (L)
198 S
Arginase Ozmeriç et al., 2000 (C); Gheren et al., 2008 (I)*;
Pereira et al., 2012 (I)
160 S





Isaza-Guzmán et al., 2015 (C)* 149 P
Lactoferrin Fine et al., 2002 (C); Jentsch et al., 2004 (I); Glimvall
et al., 2012 (C)*
79 Groenink et al., 1999 (C) 39 P
Dipeptidyl peptidase Aemaimanan et al., 2009 (C)* 90 P
Chemerin Özcan et al., 2015 (C)* 72 P
Procalcitonin Hendek et al., 2015 (C)* 72 P
Calprotectin Ramseier et al., 2009 (C) 99 P
Myeloperoxidase Meschiari et al., 2013 (C) 72 P
IL-18 Banu et al., 2015 (C) 60 P
TLR4 Banu et al., 2015 (C) 60 P
β-glucuronidase Lamster et al., 2003 (C)*; Yoon et al., 2012 (C) 497 Pietruska et al., 2006 (I) 16 P
CRP Pederson et al., 1995 (C); Christodoulides et al., 2007
(C); Shojaee et al., 2013 (C)*
186 Aurer et al., 2005 (C) 51 P
IL-6 Costa et al., 2010 (C); Ebersole et al., 2013 (C);
Prakasam and Srinivasan, 2014 (C)
210 Teles et al., 2009 (C);
Gursoy et al., 2009 (C);
Ramseier et al., 2009 (C);
Rathnayake et al., 2013 (C);
Khalaf et al., 2014 (C)
873 Q
IL-8 Fine et al., 2014 (L) 70 Teles et al., 2009 (C);
Rathnayake et al., 2013
(C)*; Khalaf et al., 2014 (C)
609 Q
TNFα Frodge et al., 2008 (C) 42 Teles et al., 2009 (C);
Ramseier et al., 2009 (C);
Gursoy et al., 2009 (C);
Mirrielees et al., 2010 (C);
Ebersole et al., 2013 (C)
567 Q
Metabolites Nitric oxide Reher et al., 2007 (C)*; Khorsavi Samani et al., 2012
(C); Parwani et al., 2012 (I)*; Han et al., 2013 (C);
Sundar et al., 2013 (C)
466 S
8-hydroxydeoxyguanosine Sugano et al., 2003 (I); Sawamoto et al., 2005 (I);
Takane et al., 2005 (C); Canakçi et al., 2009a (C);
Canakçi et al., 2009b (C); Sezer et al., 2012 (C)*
297 S
Platelet activating factor McManus and Pinckard, 2000 (C) 165 P
Neopterin Ozmeriç et al., 2002 (C) 30 P
ω-3 (docosapentaenoate)
and ω-6 (linoleate and
arachidonate) fatty acids
Barnes et al., 2014 (C) 80 P
†Combined from multiple studies, C, cross-sectional study; L, longitudinal study; I, interventional study; *, correlation with clinical parameters; S, strong; P, potential; Q, questionable.
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TABLE 3 | Host-derived salivary biomarkers associated with soft tissue destruction.
Salivary biomarkers Supporting reports No difference or contradictory reports Strength
References Study size† References Study size
Protein MMP-8 Gorska and Nedzi-Gora, 2006(I); Miller et al., 2006
(C)*; Christodoulides et al., 2007 (C); Ramseier et al.,
2009 (C); Mirrielees et al., 2010 (C); Costa et al., 2010
(C); Gursoy et al., 2010 (C); Gursoy et al., 2013 (C);
Ebersole et al., 2013 (C); Meschiari et al., 2013 (I);
Rathnayake et al., 2013 (C)*
1371 S
HGF Wilczynska-Borawska et al., 2006 (C)*; Scannapieco
et al., 2007 (L); Rudrakshi et al., 2011 (C)*; Lönn et al.,
2014 (C)
222 S
Aspartate aminotransferase Nomura et al., 2006 (C); Totan et al., 2006 (C); Nomura
et al., 2012 (L); Banu et al., 2015 (C)
382 P
Lactate dehydrogenase de la Peña et al., 2005 (I); Nomura et al., 2006 (C);
Kugahara et al., 2008 (C); Nomura et al., 2012 (L)
568 Gursoy et al., 2009 (I) 165 P
MMP-9 Ramseier et al., 2009 (C); Isaza-Guzmán et al., 2011
(C)*; Gursoy et al., 2013 (C)
452 Gorska and Nedzi-Gora,
2006 (I)
40 P
TIMP-2 Meschiari et al., 2013 (I) 72 P
Alanine aminotransferase Nomura et al., 2012 (L); Banu et al., 2015 (C) 145 Nomura et al., 2006 (C);
Totan et al., 2006 (C)
237 Q
TIMP-1 Gursoy et al., 2010 (C); Isaza-Guzmán et al., 2011 (C)* 288 Hayakawa et al., 1994 (C);
Gorska and Nedzi-Gora,
2006 (I); Meschiari et al.,










Barnes et al., 2011 (C) 68 P
†Combined from multiple studies, C, cross-sectional study; L, longitudinal study; I, interventional study; *, correlation with clinical parameters; S, strong; P, potential; Q, questionable.
Host-derived Biomarkers Associated with Bone
Destruction
Salivary biomarkers of bone remodeling can be used as indicators
of bone destruction in periodontitis. These include alkaline
phosphatase, osteonectin, RANKL, and calcium (Table 4). A
positive correlation between the levels of salivary calcium and
CAL has been reported (Sutej et al., 2012).
Further Considerations
Among the various salivary biomarkers listed, P. gingivalis has
been shown to satisfy all four requirements of ideal biomarkers
for periodontitis in at least one study for each requirement.
However, single biomarker detection may not be effective
enough for accurate diagnoses without false-positive or false-
negative results. Periodontitis is a disease that involves complex
interactions between bacteria and the host immune system.
The combination of the host-derived biomarkers, which reflect
inflammation, soft tissue destruction, and bone destruction
together with bacteria-derived biomarkers, may be useful to
diagnose not only the presence of periodontitis but also the
degree of progression and the response to therapy. A number of
host-derived biomarkers have already shown strong associations
with periodontitis.
The fact that the concentration of biomarkers can be affected
by the saliva flow rate, circadian rhythm, age, the physiological
status of the patients, and other factors raises concern over
the accuracy and reproducibility of diagnoses using salivary
biomarkers (Nový, 2014). Although within-subject correlations
between unstimulated and stimulated samples and over time
have been reported for some salivary proteins (Rudney et al.,
1985), such studies have not been done for all salivary proteomes
or metabolomes. Nevertheless, many biomarkers, in numerous
studies, have shown consistent associations with periodontitis.
For example, significantly higher levels of salivary MMP-8 in
periodontitis than in healthy controls were observed in six
studies that used the non-stimulatory whole saliva samples
(Miller et al., 2006; Christodoulides et al., 2007; Ramseier et al.,
2009; Costa et al., 2010; Mirrielees et al., 2010; Ebersole et al.,
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TABLE 4 | Host-derived salivary biomarkers associated with hard tissue destruction.
Salivary biomarkers Supporting reports No difference or contradictory reports Strength
References Study size† References Study size
Protein Alkaline phosphatase Totan et al., 2006 (C); Kugahara et al., 2008 (C); Dabra
and Singh, 2012 (C)
331 Nomura et al., 2012 (L) 85 P
Osteonectin Scannapieco et al., 2007 (L); Ng et al., 2007 (C)* 80 P
RANKL Buduneli et al., 2008 (C); Tobón-Arroyave et al., 2012
(C)*
195 Frodge et al., 2008 (C) 42 P
Osteoprotegerin Ramseier et al., 2009 (C); Tobón-Arroyave et al., 2012
(C)*; Hassan et al., 2015 (I)
269 Miller et al., 2006 (C)*;
Buduneli et al., 2008 (C);
Costa et al., 2010 (C);
Al-Sabbagh et al., 2012 (C)*
282 Q
Metabolites Calcium Acharya et al., 2011 (C); Sutej et al., 2012 (C)* 67 P
Pyridinoline cross-linked
carboxyterminal
telopeptide of type I
collagen
Gursoy et al., 2010 (C) 165 Frodge et al., 2008 (C);
Ramseier et al., 2009 (C);
Al-Sabbagh et al., 2012 (C);
Gursoy et al., 2013 (C)
386 Q
†Combined from multiple studies, C, cross-sectional study; L, longitudinal study; I, interventional study; *, correlation with clinical parameters; S, strong; P, potential; Q, questionable.
2013) and in five studies that used stimulated whole saliva
samples (Gorska and Nedzi-Gora, 2006; Gursoy et al., 2010, 2013;
Meschiari et al., 2013; Rathnayake et al., 2013). These findings
suggest that within-subject variations in the concentration of
salivary biomarkers can be overcome for diagnostic purposes
if a biomarker with substantial inter-group differences is
chosen.
POC Devices in Periodontology
A few POC devices have been developed for the salivary diagnosis
of periodontitis. A device called the Integrated Microfluidic
Platform for Oral Diagnostics (IMPOD) was able to detect
salivary proteins with a low sample volume requirements (10µL)
and considerable sensitivity (nM-pM) by integrating sample
pretreatment (filtering, enrichment, mixing) with electrophoretic
immunoassays and a laser-induced fluorescence detection
system. Using this device, rapid (<10min) measurements of
MMP-8, TNF-α, IL-6, and CRP in saliva were performed (Herr
et al., 2007a,b). However, validation in the clinical setting has not
yet been reported.
A group at the University of Texas at Austin developed
a lab-on-a-chip (LOC) system that integrates microfluidics
and a fluorescence-based optical system in which sandwich
immunoassays are performed on chemically sensitized beads.
They reported the application of the LOC system for the
multiplex measurement of three salivary biomarkers, C-reactive
protein, MMP-8, and IL-1β, which are related to the clinical
expression of periodontitis. The LOC approach yielded a limit
of detection five orders of magnitude lower than that of a
standard ELISA, and the results obtained by the LOC approach
were consistent with ELISA results (Christodoulides et al.,
2007). Whether the POC device using this LOC approach can
accurately measure levels of the salivary biomarker MMP-8 and
thus indicate if a patient has periodontal health, gingivitis or
periodontal disease is currently being studied in a clinical trial
(NCT02403297 at ClinicalTrials.gov).
Suggestions for Organizing the
International Consortium for Salivary
Biomarkers of Periodontitis
For the success of POC diagnostics of periodontitis using
saliva, it is important to validate the candidate biomarkers
with large populations which suitably account for diversity
such as those related to race, region, gender, and age. In
periodontal research, full-mouth or selected teeth have been
examined to diagnose periodontitis, and different criteria have
been also used to classify the severity of periodontitis. Such
variations in the classifications of patients make it difficult to
integrate the results of different studies. Furthermore, variations
in saliva sampling methods (e.g., resting vs. stimulatory, whole
vs. individual gland sampling), target biomarkers, and detection
methods of salivary biomarkers prevent direct comparisons of
the data obtained from different studies or centers. We propose
the organization of an International Consortium for Salivary
Biomarkers of Periodontitis (ICSBP). The ICSBP can put forth
collaborative efforts to create standardized protocols for clinical
research, including a uniform method for clinical diagnoses of
periodontitis. In addition, the ICSBP can accelerate the validation
of biomarkers and the implementation of salivary diagnostics by
sharing clinical samples and experience.
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